Recent concern over existing drug-eluting stents, for the treatment of myocardial ischaemia, has led to the development of approaches that seek to inhibit restenosis while promoting the recovery of a functional endothelium. Prostacyclin analogues may be worthy candidates for use within a drug-eluting stent by virtue of their wide profile of vasoprotective effects. This article reviews recent developments in this area, and in so doing, reveals the future challenges for the further development of this technology.
Skip Nav Destination
Conference Article| October 25 2007
Prostacyclin analogues: the next drug-eluting stent?
C. McCormick 1
*Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, John Arbuthnott Bldg, 27 Taylor Street, Glasgow G4 0NR, Scotland, U.K.
1To whom correspondence should be addressed (email firstname.lastname@example.org).
Search for other works by this author on:
C. McCormick, R.M. Wadsworth, R.L. Jones, S. Kennedy; Prostacyclin analogues: the next drug-eluting stent?. Biochem Soc Trans 1 November 2007; 35 (5): 910–911. doi: https://doi.org/10.1042/BST0350910
Download citation file:
Don't already have an account? Register
Get Access To This Article
Buy This Article